Literature DB >> 17138012

The neurologic aspects of PHACE: case report and review of the literature.

Geoffrey L Heyer1, William S Millar, Saadi Ghatan, Maria C Garzon.   

Abstract

PHACE syndrome is a neurocutaneous disorder characterized by large cervicofacial infantile hemangiomas and associated anomalies of the brain, cerebrovasculature, aorta, heart, and eyes. Two categories of neurologic disease are observed among PHACE patients: congenital malformations of the cerebellum, cerebrum, and cerebral vasculature and progressive stenoses and occlusions of principal cerebral arteries. A subgroup of patients develops a moyamoya-like vasculopathy and consequent ischemic strokes. This report details the clinical course and management of a young female with PHACE and reviews the various neurologic aspects of this neurocutaneous disorder. This patient presented with high-grade stenoses of the internal carotid arteries bilaterally, formation of extensive vascular collaterals, and multiple ischemic strokes. She underwent bilateral pial-synangiosis procedures and has not had stroke recurrence in 2 years of follow-up. The presence of a characteristic infantile hemangioma necessitates further evaluation for the extracutaneous features of PHACE. In cases of steno-occlusive vasculopathy, we recommend early consideration of encephaloduroarteriosynangiosis or a commensurate revascularization procedure.

Entities:  

Mesh:

Year:  2006        PMID: 17138012     DOI: 10.1016/j.pediatrneurol.2006.06.021

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

1.  Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.

Authors:  Jeffrie Hadisurya; Stephanie Guey; Lou Grangeon; Dagmar Wieczorek; Michaelle Corpechot; Jan Claudius Schwitalla; Markus Kraemer
Journal:  Childs Nerv Syst       Date:  2019-04-29       Impact factor: 1.475

Review 2.  Limb-shaking transient ischemic attacks in an adult PHACE syndrome: a case report and review of the literature.

Authors:  Ping Song Chou; Yuh Cherng Guo
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

3.  Growth Hormone Induces Recurrence of Infantile Hemangiomas After Apparent Involution: Evidence of Growth Hormone Receptors in Infantile Hemangioma.

Authors:  Naikhoba C O Munabi; Qian Kun Tan; Maria C Garzon; Gerald G Behr; Carrie J Shawber; June K Wu
Journal:  Pediatr Dermatol       Date:  2015-02-18       Impact factor: 1.588

4.  Adult presentation of PHACES syndrome.

Authors:  S S Arora; B M Plato; R J Sattenberg; R K Downs; K S Remmel; J O Heidenreich
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

Review 5.  Update on pediatric extracranial vascular anomalies of the head and neck.

Authors:  Katherine B Puttgen; Monica Pearl; Aylin Tekes; Sally E Mitchell
Journal:  Childs Nerv Syst       Date:  2010-08-10       Impact factor: 1.475

6.  PHACE/S syndrome: a syndromic infantile segmental hemangioma.

Authors:  Siddram J Patil; Amol A Moray; Viralam S Kiran; Ravindra R Battu
Journal:  Indian J Pediatr       Date:  2010-10-17       Impact factor: 1.967

7.  PHACES association: a neuroradiologic review of 17 patients.

Authors:  V S Oza; E Wang; A Berenstein; M Waner; D Lefton; J Wells; F Blei
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-25       Impact factor: 3.825

8.  Arterial Spin-Labeling Perfusion for PHACE Syndrome.

Authors:  M D Mamlouk; A Vossough; L Caschera; M Maheshwari; C P Hess
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-19       Impact factor: 3.825

9.  PHACE association with intracranial, oropharyngeal hemangiomas, and an atypical patent ductus arteriosus arising from the tortuous left subclavian artery in a premature infant.

Authors:  Do-Hyun Kim; Jang Hwan Choi; Jung Ha Lee; Hee Sup Kim
Journal:  Korean J Pediatr       Date:  2012-01-31

10.  Lymphatic Malformation, Retinoblastoma, or Facial Cleft: Atypical Presentations of PHACE Syndrome.

Authors:  María Fernández-Ibieta; Juan Carlos López-Gutiérrez
Journal:  Case Rep Dermatol Med       Date:  2015-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.